IECM
CNMD icon

Intrinsic Edge Capital Management’s CONMED CNMD Stock Holding History

Intrinsic Edge Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,248
Closed -$8.46M – 154
2023
Q4 		$8.46M Buy
77,248
+67,248
+672% +$6.95M 0.85% 43
2023
Q3 		$1.01M Buy
+10,000
New +$1.15M 0.11% 109
2020
Q4 		– Sell
-72,778
Closed -$5.72M – 223
2020
Q3 		$5.72M Buy
+72,778
New +$5.94M 0.39% 107

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Intrinsic Edge Capital Management's CNMD Position: Q1 2024 in Review

Intrinsic Edge Capital Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 77,248 shares — an estimated $8.46M sold.

Intrinsic Edge Capital Management first reported a position in CNMD in Q3 2020 and held it in 3 quarters. The position peaked at $8.46M in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Intrinsic Edge Capital Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 77,248 CONMED shares in Q1 2024, an estimated $8.46M.
  • Intrinsic Edge Capital Management first reported a position in CONMED in Q3 2020 and held it in 3 quarters.
  • Intrinsic Edge Capital Management's CONMED position peaked at $8.46M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2024, filed 14 May 2024.